Sartorius acquires WaterSep BioSeparations

By The Science Advisory Board staff writers

Sartorius Stedim Biotech has acquired WaterSep BioSeparations for approximately $27 million plus an earn-out based on sales revenues through 2023 of up to $9 million. The transaction adds to Sartorius' filtration units for bioprocessing devices.

WaterSep BioSeparations is a privately owned company based in Malborough, MA, which employs 15 people and is on track to earn revenue of approximately $2.5 million in 2020. The company develops, manufactures, and markets hollow-fiber membrane devices (crossflow filtration) and presterilized assemblies for upstream and downstream biopharmaceutical applications.
Copyright © 2020

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?